View Author
Branzi, A.
(Angelo Branzi)
patient fluvastatin group trial study ischaemia placebo fluvastatin group event placebo group angioplasty disease cholesterol treatment death heart follow-up infarction effect level balloon angioplasty restenosi hospital analysis balloon stress lesion angina procedure medication result angiographic serruy statin lipid table point ischemia end point population segment randomized flare trial medication reduction laboratory difference luminal month artery therapy value 6 months investigator survival rotterdam incidence dobutamine baseline luminal diameter angiography dobutamine stress echocardiography stent prevention outcome cardiol evaluation multivessel end-point index procedure diameter 80 mg /d eur heart j multivessel disease luminal loss october exercise safety echocardiography erasmus mc
3 Most Recent Publications
|
Long term outcome in patients with silent versus symptomatic ischaemia during dobutamine stress echocardiography
(Article)
Biagini, E. Pedone, C. Bountioukos, M. Roelandt, J.R.T.C. Domburg, R.T. van Vourvouri, E.C. Poldermans, D. Rapezzi, C. Branzi, A. Schinkel, A.F. Bax, J.J. Rizzello, V. Krenning, B.J. |
2005-01-01
|
|
Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial
(Article)
Meier, B. Macaya Miguel, C.M. Serruys, P.W.J.C. Kokott, N. Puel, J. Vrolix, M.C. Branzi, A. Bertolami, M.C. Jackson, G. Strauss, B.H. Feyter, P.J. de |
2002-01-01
|
|
A randomized placebo-controlled trial of fluvastatin for prevention of restenosis after successful coronary balloon angioplasty; final results of the fluvastatin angiographic restenosis (FLARE) trial
(Article)
Shepherd, J. Suryapranata, H. Branzi, A. Serruys, P.W.J.C. Foley, D.P. Pfister, P.J. Feyter, P.J. de Es, G.A. van Melkert, R. Jackson, G. Bonnier, J.J.R.M. Macaya Miguel, C.M. Vrolix, M.C. |
1999-01-01
|